ENT_home_illus_banner_v1-01
Trillions of microbes call us home. These microbes, their genomic potential and their repertoire of activity form the human microbiome, which performs a wide range of physiological functions that preserve our health and prevent disease. At EnteroBiotix, we are building a global pharmaceutical company focused on maximising the microbiome’s therapeutic potential. 
 
Our dynamic and experienced team is committed to dramatically improving healthcare through unlocking the therapeutic potential of the microbiome. We are developing and advancing three core product portfolios that build on the science of a medical treatment called faecal microbiota transplantation (FMT), with an initial focus on infections caused by antibiotic-resistant bacteria.

We have deep operational experience and capabilities, including fully integrated ISO-accredited microbial collection and GMP-compliant processing capabilities under a ‘specials’ license from the Medicines and Healthcare Products Regulatory Agency (MHRA). Since its formation in March 2017, EnteroBiotix has raised over £2.5m in seed funding and has a strategic collaboration with the Academic Health Science Partnership and National Health Service in Tayside, Scotland.

I am always eager to speak with passionate and driven colleagues that may wish to join us on our missions. If you think you would be a good fit for our team then please email your CV and covering letter to [email protected]